The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies
Open Access
- 1 January 2012
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 30 (5), 886-892
- https://doi.org/10.1016/j.vaccine.2011.11.104
Abstract
No abstract availableKeywords
Funding Information
- MedImmune, LLC
- MedImmune
This publication has 27 references indexed in Scilit:
- Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young childrenVaccine, 2010
- Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive ChildrenThe Pediatric Infectious Disease Journal, 2009
- Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in childrenVaccine, 2005
- Strategy for Distribution of Influenza Vaccine to High-Risk Groups and ChildrenAmerican Journal of Epidemiology, 2005
- Burden of Influenza in Children in the CommunityThe Journal of Infectious Diseases, 2004
- Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25‐Year Prospective StudyThe Journal of Infectious Diseases, 2002
- The Japanese Experience with Vaccinating Schoolchildren against InfluenzaNew England Journal of Medicine, 2001
- Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineThe Journal of Pediatrics, 2000
- Is It Time to Give Influenza Vaccine to Healthy Infants?New England Journal of Medicine, 2000
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998